Program Overview

Biomanufacturing (BioMAN)
The MIT CBI BioMAN Program is a collaborative research program that creates innovative tools and technologies that reduce the cost of biomanufacturing processes and improve our ability to deliver safe high quality biopharmaceutical products.

Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB)
The MIT CBI CAACB is a collaborative consortium that aims to analyze and advance biopharmaceutical industry practices that lead to the safe and reliable manufacture of life-saving biotherapeutic medications.

NEW Drug Development ParaDIGmS (NEWDIGS)
The MIT CBI NEWDIGS program is a unique collaboration for transforming the global healthcare innovation system to deliver greater value to all stakeholders and to ensure its sustainability.

sanofi Biomedical Innovation Award Program (saBIP)
The sanofi Biomedical Innovation Award Program offers MIT faculty and researchers the opportunity to compete for funding in specific areas of biomedical science and engineering of interest to the program’s sponsor, sanofi.

Completed Research Projects:

Economics of Stratified Medicine
Development and Validation of Tools To Enhance Decision-making Related to “Stratified Medicine”

Strategic Allocation of Global Clinical Trials
Advancing the Strategic Decision Making Process Behind the Selection of Where to Place Patient Recruitment Sites

Enhancing the Productivity of Collaborative Innovation
Comparative Analysis of Established Bioclusters in San Diego, Singapore, and Boston